Profile data is unavailable for this security.
About the company
UFP Technologies, Inc. is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other engineered custom products. Its single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, surfaces and support, wound care, wearables, orthopedic soft goods, and orthopedic implants. It is also providing engineered products and components. Typical applications of its products include military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It also engineers’ components for automotive use, such as interior trim and structural applications. These components are produced using a compression molding process. It also develops and manufactures single-use safe patient handling systems, thermoformed, heat-sealed implantable medical device components, custom-engineered foam and thermoplastic components.
- Revenue in USD (TTM)417.47m
- Net income in USD49.55m
- Incorporated1993
- Employees3.09k
- LocationUFP Technologies Inc100 Hale StreetNEWBURYPORT 01950United StatesUSA
- Phone+1 (978) 352-2200
- Websitehttps://www.ufpt.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novocure Ltd | 549.96m | -168.70m | 1.91bn | 1.45k | -- | 5.26 | -- | 3.47 | -1.58 | -1.58 | 5.13 | 3.35 | 0.4639 | 3.62 | 8.11 | 378,502.40 | -14.23 | -7.74 | -16.44 | -8.95 | 75.83 | 77.22 | -30.67 | -14.69 | 6.22 | -- | 0.6437 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
| Patterson Companies, Inc. | 6.53bn | 168.41m | 1.94bn | 7.60k | 12.00 | 2.03 | 7.51 | 0.2963 | 1.83 | 1.83 | 71.22 | 10.80 | 2.27 | 5.86 | 15.35 | 859,640.70 | 5.84 | 1.13 | 10.15 | 1.81 | 21.03 | 20.98 | 2.57 | 0.5157 | 0.6723 | 7.91 | 0.4474 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
| Omnicell Inc | 1.08bn | -20.76m | 1.97bn | 3.65k | -- | 1.64 | 30.44 | 1.82 | -0.4558 | -0.4558 | 23.63 | 26.15 | 0.4818 | 5.64 | 4.20 | 296,013.40 | -0.9258 | 1.73 | -1.12 | 2.25 | 41.63 | 46.69 | -1.92 | 2.92 | 2.22 | -- | 0.322 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
| LeMaitre Vascular Inc | 205.62m | 37.68m | 2.00bn | 614.00 | 53.23 | 6.25 | 42.22 | 9.71 | 1.67 | 1.67 | 9.11 | 14.22 | 0.5964 | 1.13 | 7.19 | 334,887.60 | 10.93 | 9.02 | 11.81 | 9.93 | 67.70 | 65.83 | 18.32 | 15.45 | 5.86 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Premier Inc | 1.35bn | 119.54m | 2.05bn | 2.90k | 19.74 | 1.10 | 8.70 | 1.52 | 1.04 | 1.04 | 11.78 | 18.68 | 0.3976 | 5.85 | 3.07 | 464,262.40 | 3.15 | 7.08 | 4.10 | 8.95 | 65.96 | 61.29 | 7.93 | 16.05 | 0.8951 | -- | 0.2775 | 27.32 | 0.7684 | 2.03 | -31.70 | -11.93 | -2.76 | -- |
| Rxsight Inc | 115.18m | -36.77m | 2.15bn | 374.00 | -- | 7.80 | -- | 18.66 | -1.01 | -1.01 | 3.14 | 6.95 | 0.46 | 2.08 | 5.90 | 307,962.60 | -14.69 | -- | -15.83 | -- | 66.26 | -- | -31.93 | -- | 13.34 | -- | 0.0005 | -- | 81.77 | -- | 27.19 | -- | -- | -- |
| Irhythm Technologies Inc | 537.09m | -131.59m | 2.22bn | 2.00k | -- | 22.35 | -- | 4.13 | -4.26 | -4.26 | 17.40 | 3.18 | 0.7965 | 11.79 | 7.86 | 268,545.50 | -19.51 | -21.92 | -22.66 | -26.77 | 67.19 | 69.39 | -24.50 | -25.75 | 6.76 | -13.78 | 0.8667 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
| Conmed Corp | 1.28bn | 98.59m | 2.34bn | 4.00k | 24.10 | 2.66 | 13.74 | 1.83 | 3.15 | 3.15 | 40.81 | 28.61 | 0.5538 | 1.75 | 5.45 | 318,998.30 | 4.28 | 0.8972 | 4.94 | 1.02 | 55.32 | 54.95 | 7.73 | 1.65 | 1.13 | 4.20 | 0.5228 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Enovis Corp | 1.91bn | -107.11m | 2.44bn | 6.55k | -- | 0.7286 | 16.86 | 1.27 | -1.96 | -1.65 | 35.01 | 59.90 | 0.3872 | 1.53 | 5.52 | 292,209.20 | -2.16 | -0.3569 | -2.37 | -0.41 | 57.30 | 48.19 | -5.57 | -1.06 | 1.08 | 0.836 | 0.2902 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| Myriad Genetics, Inc. | 802.20m | -155.20m | 2.59bn | 2.70k | -- | 3.49 | -- | 3.22 | -1.80 | -1.80 | 9.20 | 8.15 | 0.7061 | 10.21 | 6.99 | 297,111.10 | -13.66 | -- | -16.32 | -- | 69.06 | -- | -19.35 | -- | 1.78 | -113.89 | 0.0498 | -- | 11.03 | -- | -135.09 | -- | -- | -- |
| Inari Medical Inc | 547.47m | -57.05m | 2.59bn | 1.30k | -- | 6.09 | -- | 4.72 | -0.9838 | -0.9838 | 9.43 | 7.29 | 0.9141 | 1.59 | 7.56 | 421,133.80 | -9.53 | -0.5941 | -11.39 | -0.6696 | 87.15 | 89.06 | -10.42 | -0.6295 | 1.45 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| UFP Technologies Inc | 417.47m | 49.55m | 2.59bn | 3.09k | 52.72 | 8.36 | 42.26 | 6.21 | 6.41 | 6.41 | 54.02 | 40.42 | 1.02 | 4.26 | 6.68 | 134,971.50 | 12.08 | 9.69 | 13.85 | 10.95 | 28.02 | 26.33 | 11.87 | 10.14 | 1.63 | 21.63 | 0.1024 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| 10X Genomics Inc | 631.73m | -239.78m | 2.66bn | 1.26k | -- | 3.67 | -- | 4.21 | -2.02 | -2.02 | 5.31 | 6.01 | 0.6583 | 2.59 | 7.06 | 501,773.60 | -24.99 | -25.52 | -28.04 | -29.05 | 64.70 | 75.88 | -37.96 | -48.53 | 4.42 | -- | 0.00 | -- | 19.81 | 33.43 | -53.67 | -- | 49.15 | -- |
| LivaNova PLC | 1.21bn | -16.59m | 2.77bn | 2.90k | -- | 2.23 | 92.45 | 2.29 | -0.3133 | -0.3133 | 22.29 | 22.88 | 0.5046 | 2.52 | 6.26 | 417,149.00 | -0.6876 | -6.01 | -0.7843 | -7.42 | 67.64 | 66.99 | -1.36 | -13.56 | 2.94 | 2.19 | 0.3347 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| Tandem Diabetes Care Inc | 796.00m | -136.49m | 2.79bn | 2.40k | -- | 11.93 | -- | 3.51 | -2.09 | -2.09 | 12.21 | 3.57 | 0.8449 | 2.62 | 8.09 | 331,667.50 | -14.49 | -10.08 | -18.58 | -12.23 | 49.06 | 51.77 | -17.15 | -11.59 | 2.38 | -- | 0.598 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| Quidelortho Corp | 2.83bn | -1.86bn | 3.11bn | 7.10k | -- | 0.9775 | -- | 1.10 | -27.79 | -27.79 | 42.35 | 47.30 | 0.372 | 2.58 | 9.15 | 399,239.40 | -24.40 | 11.34 | -27.51 | 12.91 | 47.89 | 62.71 | -65.60 | 20.93 | 0.7929 | 0.7895 | 0.4469 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
Data as of Sep 19 2024. Currency figures normalised to UFP Technologies Inc's reporting currency: US Dollar USD
49.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2024 | 993.98k | 12.95% |
| Neuberger Berman Investment Advisers LLCas of 30 Jun 2024 | 670.26k | 8.73% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 507.60k | 6.61% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 293.61k | 3.83% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 279.45k | 3.64% |
| Wasatch Advisors LPas of 30 Jun 2024 | 254.29k | 3.31% |
| Congress Asset Management Co. LLPas of 30 Jun 2024 | 245.32k | 3.20% |
| AltraVue Capital LLCas of 30 Jun 2024 | 184.72k | 2.41% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 181.95k | 2.37% |
| Geode Capital Management LLCas of 30 Jun 2024 | 169.66k | 2.21% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
